Qingdao Baheal Medical INC. (SHE:301015)
25.68
+0.64 (2.56%)
Sep 30, 2026, 3:04 PM CST
SHE:301015 Market Cap
SHE:301015 has a market cap or net worth of 13.5 billion as of October 1, 2026. Its market cap has decreased by -6.52% in one year.
Market Cap
13.50B
Enterprise Value
15.49B
Revenue
7.31B
Ranking
n/a
PE Ratio
25.75
Stock Price
25.68
ChartMarket Cap Chart
Since June 30, 2021, SHE:301015's market cap has decreased from 29.49B to 13.50B, a decrease of -54.23%. That is a compound annual growth rate of -13.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 13.50B | 8.81% |
| Dec 31, 2025 | 12.40B | -2.52% |
| Dec 31, 2024 | 12.73B | -32.42% |
| Dec 29, 2023 | 18.83B | 50.42% |
| Dec 30, 2022 | 12.52B | -21.32% |
| Dec 31, 2021 | 15.91B | -46.05% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 53.18B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 29.73B |
| Jointown Pharmaceutical Group | 24.73B |
| China National Medicines Corporation | 19.47B |
| Liaoning Cheng Da | 15.34B |
| China Meheco Group | 13.13B |
| China National Accord Medicines Corporation | 11.14B |
| C.Q. Pharmaceutical Holding | 8.91B |